Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (18)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Smets, Y. F.
Right arrow Articles by Lemkes, H. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smets, Y. F.
Right arrow Articles by Lemkes, H. H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrology Dialysis Transplantation, Vol 12, Issue 4 764-771, Copyright © 1997 by Oxford University Press


ORIGINAL ARTICLES

Infectious disease complications of simultaneous pancreas kidney transplantation

YF Smets, JW van der Pijl, JT van Dissel, J Ringers, JW de Fijter and HH Lemkes
Department of Endocrinology, Leiden University Hospital, The Netherlands.

BACKGROUND: Although technical success rate of simultaneous pancreas kidney (SPK) transplantation in insulin-dependent diabetes mellitus (IDDM) patients with diabetic nephropathy has improved, morbidity remains high due to infection and rejection. The purpose of this study was to analyse infections encountered in our series of SPK transplants, using a restrictive antibiotic prophylaxis policy. METHODS: We reviewed all infectious diseases after 66 consecutive bladder-drained SPK transplantations in 64 IDDM patients with end-stage renal disease due to diabetic nephropathy. During follow-up, the perioperative antibiotic regimen was altered (from 5 days preemptive therapy with multiple drugs to 1 day prophylaxis with cefamandole), and long-term viral prophylaxis (high-dose aciclovir) was introduced. For post-operative urinary tract or opportunistic infection, no prophylaxis was given. RESULTS: Overall mean infection rate was 2.9 infections/ patient/year after a mean follow-up of 2.3 years. Surgical site infections (SSI) were seen in 30% of the patients, with Enterococci present in 47%. Logistic regression showed one day cefamandole prophylaxis to be associated with SSI, but there was no significant influence of SSI on either graft or patient survival. Forty-eight percent of all infections were lower urinary tract infections (UTI). There were 59 first UTIs (89%), probably related to long-term Foley catheter use, and 47 second UTIs (71%). Subsequent UTIs were not microbiologically related to first UTIs. Cytomegalovirus (10 patients) and other opportunistic agents did not cause mortality or graft loss. Five grafts were lost due to infection (SSI three times, post-transplant lymphoproliferative disease twice). Only one patient died because of infection (2%). CONCLUSIONS: Infectious diseases after SPK transplantation caused significant morbidity but did not influence either patient or graft survival. A change in prophylactic policy for both SSI as well as recurrent UTI, combined with earlier Foley removal, may lower incidences of these infections.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CJASNHome page
P. P. Reese and A. K. Israni
Best Option for Transplant Candidates with Type 1 Diabetes and a Live Kidney Donor: A Bird in the Hand is Worth Two in the Bush
Clin. J. Am. Soc. Nephrol., April 1, 2009; 4(4): 700 - 702.
[Full Text] [PDF]


Home page
J Intensive Care MedHome page
N. Hlava, C. U. Niemann, M. A. Gropper, and M. L. Melcher
Analytic Reviews: Postoperative Infectious Complications of Abdominal Solid Organ Transplantation
J Intensive Care Med, January 1, 2009; 24(1): 3 - 17.
[Abstract] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. P. Berger, A. Roos, M. J.K. Mallat, A. F.M. Schaapherder, I. I. Doxiadis, C. van Kooten, F. W. Dekker, M. R. Daha, and J. W. de Fijter
Low Pretransplantation Mannose-Binding Lectin Levels Predict Superior Patient and Graft Survival after Simultaneous Pancreas-Kidney Transplantation
J. Am. Soc. Nephrol., August 1, 2007; 18(8): 2416 - 2422.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
G. A. Knoll and G. Nichol
Dialysis, Kidney Transplantation, or Pancreas Transplantation for Patients with Diabetes Mellitus and Renal Failure: A Decision Analysis of Treatment Options
J. Am. Soc. Nephrol., February 1, 2003; 14(2): 500 - 515.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
J. W. Jukema, Y. F. C. Smets, J. W. van der Pijl, A. H. Zwinderman, H. W. Vliegen, J. Ringers, J. H. C. Reiber, H. H. P. J. Lemkes, E. E. van der Wall, and J. W. de Fijter
Impact of Simultaneous Pancreas and Kidney Transplantation on Progression of Coronary Atherosclerosis in Patients With End-Stage Renal Failure due to Type 1 Diabetes
Diabetes Care, May 1, 2002; 25(5): 906 - 911.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
A Kumar, C G Newstead, J P A Lodge, and A M Davison
Combined kidney and pancreatic transplantation
BMJ, April 3, 1999; 318(7188): 886 - 887.
[Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
R. P. ROBERTSON, T. V. HOLOHAN, S. GENUTH, R. P. Robertson, T. V. Holohan, and S. Genuth
Pancreas Transplantation for Type 1 Diabetes-- A Summation
J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 1868 - 1874.
[Full Text]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.